fetching data ...

POS0165 (2024)
MACHINE LEARNING-BASED APPROACHES TOWARDS STRATIFICATION OF DISEASE SEVERITY AND ORGAN DAMAGE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Keywords: Biomarkers, Outcome measures, Artificial Intelligence
P. Garantziotis1,2, D. Nikolopoulos3,4, C. Adamichou5, A. Fanouriakis6, A. Repa5, D. Boumpas1,6, P. Sidiropoulos5,7, G. K. Bertsias5,7
1Biomedical Research Foundation Academy of Athens, Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Athens, Greece
2Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Department of Internal Medicine 3-Rheumatology and Immunology, Erlangen, Germany
3Laboratory of Autoimmunity and Inflammation, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation Academy of Athens, Athens, Greece
4Karolinska Institutet, Division of Rheumatology, Department of Medicine Solna, Stockholm, Sweden
5Medical School University of Crete, Rheumatology, Clinical Immunology and Allergy Department, Crete, Greece
6National and Kapodistrian University of Athens Medical School, 4th Department of Internal Medicine, Attikon University Hospital, Athens, Greece
7Institute of Molecular Biology and Biotechnology, Laboratory of Autoimmunity-Inflammation, Crete, Greece

Background: Organ damage is a key determinant of unfavorable long-term prognosis and increased mortality, thus being reflective of disease severity in SLE patients.


Objectives: To develop a clinical, machine learning based model for the prediction of early organ damage in SLE towards disease severity stratification.


Methods: Using a cohort of 914 adults with SLE [1], panels of deconvoluted classification criteria [ACR 1997 (ACR), SLICC 2012 (SLICC) and EULAR/ACR 2019 (EULAR)] and non-criteria features present at any timepoint throughout the first five years since SLE diagnosis were assessed. Permanent organ damage was evaluated using the SLICC/ACR Damage Index (SDI). We randomly divided the patient cohort into a training (70%) and a test (30%) set. Employing feature selection algorithms, the smallest set of clinical features that most accurately predicted early organ damage accrual (defined as SDI increase within the first 5 years since SLE diagnosis) was selected. Five different prediction models (random forest (RF), logistic regression (glm), linear discriminant analysis (LDA), k-nearest neighbors (KNN), extreme gradient boosting (XGBoost)) were adopted. The best model in 10-fold cross-validation was tested in the test set. Accuracy, sensitivity, specificity, and area under (AUC) the receiver operating curve (ROC) were determined in the test set.


Results: The LDA model demonstrated the highest performance in predicting early organ damage with an AUC of 0.831 (95% CI: [0.7817, 0.8739]) with sensitivity of 0.955 and specificity of 0.463. The leading predictors included synovitis, non-scarring alopecia, acute cutaneous lupus, SLICC 2012-based neurologic disorder, leukopenia, and the age at the time of SLE diagnosis. The XGBoost model exhibited the highest specificity (0.841) with an accuracy of 0.805 (95% CI: [0.7619 - 0.8241]) and sensitivity of 0.653. Age at the time of diagnosis, the presence of ACR 1997-based neurologic disorder, non-scarring alopecia, and low complement (2012 criteria) emerged as the strongest predictors in this model.


Conclusion: Machine learning methods using standard disease features may identify SLE patients at risk for early damage accrual. Further validation in external cohorts is warranted.


REFERENCES: [1] Adamichou C, Genitsaridi I, Nikolopoulos D, Nikoloudaki M, Repa A, Bortoluzzi A, Fanouriakis A, Sidiropoulos P, Boumpas DT, Bertsias GK. Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus. Ann Rheum Dis. 2021 Jun;80(6):758-766. doi: 10.1136/annrheumdis-2020-219069. Epub 2021 Feb 10. PMID: 33568388; PMCID: PMC8142436.


Acknowledgements: NIL.


Disclosure of Interests: None declared.


DOI: 10.1136/annrheumdis-2024-eular.5727
Keywords: Biomarkers, Outcome measures, Artificial Intelligence
Citation: , volume 83, supplement 1, year 2024, page 400
Session: Clinical Poster Tours: Facets of Systemic lupus (Poster Tours)